Academic drug discovery is not an oxymoron
Last week Northwestern’s Center for Molecular Innovation and Drug Discovery (CMIDD) held it’s 18th annual symposium, which CDD was proud to sponsor.
The symposium is geared towards basic research scientists to educate them in the relatively novel academic domain of drug discovery, and to provide the expertise necessary to progress their biological targets through to a marketable drug candidate. Dr. Stephen Frye of UNC’s Center for Integrative Chemical Biology and Drug Discovery (CICBDD) gave the keynote address that brought audiences from Northwestern’s campuses and other Chicago-area universities.
In his address, Dr. Frye said that “While chemical biology can be relatively successful with the typical scale of academic funding, true drug discovery requires much more investment, which can be difficult to pull together in a university setting.”
It’s not necessary to tell our blog audience that drug discovery is exciting, but arduous and expensive work. The expertise and financial resources required for successful discovery projects used to make them the sole provenance of large pharmaceutical companies, but the economic downturn of the past two decade have caused extensive cross-pollination between academia and industry. Just think about how your own career, or that of your close colleague has unfolded.
Such major academic centers as CMIDD and CICBDD have become the focal points and catalysts that bring together top-notch academic researches and provide industry-level know-how and technology. One such industry practice is systematic and secure data management, archiving and documenting of compound collections, and data mining of screening results. As important as data management is, industry software is sometimes too pricey for academic budgets and sometimes not sufficiently flexible to accommodate the collaborative projects.
We at Collaborative Drug Discovery are proud to support, well, collaborative drug discovery by delivering a professional drug research informatics software that fits the bill for virtually any drug discovery operation: from compound management with chemical registration and dose response curve fitting, to secure real time data sharing with collaborators via a hosted database.